Most Recent
Infant formula maker Care A2 Plus has launched an attack on A2 Milk, filing a lawsuit arguing the dairy giant's trade marks should be cancelled because they're too generic and are being used to sell products that don't exclusively contain the a2 protein.
The sacked boss of Orix Australia -- who escaped charges of corruption three years ago -- has settled a dispute with his former employer, including a claim by the fleet management company for $18 million in damages.
The Australian Securities and Investments Commission has filed an appeal after a judge dismissed its case alleging the Commonwealth Bank of Australia accepted conflicted remuneration through the sale of its Essential Super product, finding it was “misconceived”.
A class action against Bayer over its allegedly defective Essure contraceptive devices has admonished the drug manufacturer’s bid to shield emails considered privileged in similar US litigation, arguing “thoughts and prayers” are needed to sustain the claim.
Commonwealth Bank units CommSec and Australian Investments Exchange have been ordered to pay more than $27 million for “serious and unacceptable” system failures that led to excessive fee charges for customers.
Three law firms are meeting employee demand for workplaces that prioritise social engagement, scoring spots on the top 40 Australian workplaces to give back to the community.
Thomson Geer has snagged a construction disputes specialist from Clayton Utz to bolster its growing construction team in Sydney.
A judge has questioned AMP Financial Planning over whether it breached court orders to compensate customers after finding the firm failed to prevent a now banned adviser from churning life insurance for higher commissions.
US-based mozzarella giant Leprino Foods has succeeded in removing Canadian dairy company Saputo's 'Ascend' trade mark for non-use.
A judge has savaged Shine Lawyers over its failure to present a signed settlement agreement to the court a month after Johnson & Johnson Medical and unit Ethicon agreed to pay $300 million to settle two pelvic mesh class actions, ordering the firm to explain on the record what steps have been taken to finalise the settlement.